Inflammation and bone marrow fibrosis: Novel immunotherapeutic targets
FR Calledda, A Malara, A Balduini - Current Opinion in …, 2023 - journals.lww.com
Inflammation and bone marrow fibrosis: novel immunotherapeut... : Current Opinion in
Hematology Inflammation and bone marrow fibrosis: novel immunotherapeutic targets …
Hematology Inflammation and bone marrow fibrosis: novel immunotherapeutic targets …
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation
E Zulch, Y Inoue, J Cioccio, K Rakszawski… - Leukemia Research, 2024 - Elsevier
Primary graft failure (PGF) and multi-lineage cytopenia (MLC) increase the risk of
nonrelapse mortality in allogeneic hematopoietic cell transplants (HCT). We evaluated the …
nonrelapse mortality in allogeneic hematopoietic cell transplants (HCT). We evaluated the …
2024 update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management
H Ali, A Bacigalupo - American Journal of Hematology, 2024 - Wiley Online Library
Background Allogeneic hemopoietic stem cell transplantation (HSCT) currently remains the
only curative treatment for patients with myelofibrosis (MF). Transplant related mortality …
only curative treatment for patients with myelofibrosis (MF). Transplant related mortality …
Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes
S Jungius, FC Adam, K Grosheintz, M Medinger… - Frontiers in …, 2023 - frontiersin.org
Introduction Myelofibrosis (MF) is a rare hematopoietic stem cell disorder progressing to
bone marrow (BM) failure or blast phase. Allogeneic hematopoietic cell transplantation …
bone marrow (BM) failure or blast phase. Allogeneic hematopoietic cell transplantation …
DNA methylation of hematopoietic stem/progenitor cells from donor peripheral blood to patient bone marrow: implications for allogeneic hematopoietic stem cell …
I Laurenzana, L De Luca, P Zoppoli, G Calice… - Clinical and …, 2023 - Springer
Allogeneic hematopoietic stem cell transplantation (AHSCT) is a life-saving treatment for
selected hematological malignancies. So far, it remains unclear whether transplanted …
selected hematological malignancies. So far, it remains unclear whether transplanted …
Laboratory methods of monitoring disease response after allogeneic haematopoietic stem cell transplantation for myelofibrosis
P Smallbone, A Louw, D Purtill - Pathology, 2023 - Elsevier
The era of molecular prognostication in myelofibrosis has allowed comprehensive
assessment of disease risk and informed decisions regarding allogeneic haematopoietic …
assessment of disease risk and informed decisions regarding allogeneic haematopoietic …
[HTML][HTML] Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center
GC Seval, SC Bozdag, SK Toprak, MK Yuksel… - Balkan medical …, 2023 - ncbi.nlm.nih.gov
Background: Allogeneic hematopoietic stem cell transplantation is a well-established
approach for patients diagnosed with primary myelofibrosis and remains the only potentially …
approach for patients diagnosed with primary myelofibrosis and remains the only potentially …
Stem Cell Transplant for Myelofibrosis
SK Sharma - Basics of Hematopoietic Stem Cell Transplant, 2023 - Springer
Myelofibrosis (MF) is a myeloproliferative neoplasm where clonal expansion of stem cells
occurs and leads to cytokine-mediated intramedullary fibrosis. Allogeneic hematopoietic …
occurs and leads to cytokine-mediated intramedullary fibrosis. Allogeneic hematopoietic …
Dual-alkylator Conditioning Regimen with Busulfan and Melphalan for Bone Marrow Allogeneic Hematopoietic Stem Cell Transplantation in Patients with …
M Asai, S Matsuzawa, F Kawakami… - THE SHINSHU …, 2023 - jstage.jst.go.jp
Myelofibrosis (MF) is a myeloproliferative neoplasm associated with significant morbidity
and mortality, and allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains …
and mortality, and allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains …
Contribution of cytokines to the etiology and progression of Primary Myelofibrosis
M Mazzarini - 2024 - amsdottorato.unibo.it
Primary Myelofibrosis (PMF) is the end-stage of Philadelphia-negative myeloproliferative
neoplasms (MPN) and is characterized by fibrosis and hematopoietic failure in bone …
neoplasms (MPN) and is characterized by fibrosis and hematopoietic failure in bone …